Dana E. McClintock MD
Critical Care Medicine, Pulmonology
Associate Director
Join to View Full Profile
505 Parnassus AveSan Francisco, CA 94143
Phone+1 415-476-1079
Dr. McClintock is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Residency, Internal Medicine, 2000 - 2003
University of Virginia School of MedicineClass of 2000
Certifications & Licensure
CA State Medical License 2002 - 2025
Publications & Presentations
PubMed
- 42 citationsDeep Learning Predicts OCT Measures of Diabetic Macular Thickening From Color Fundus Photographs.Filippo Arcadu, Fethallah Benmansour, Andreas Maunz, John Michon, Zdenka Haskova
Investigative Ophthalmology & Visual Science. 2019-03-01 - 77 citationsSpecific Immune Response to Phospholipase B-Like 2 Protein, a Host Cell Impurity in Lebrikizumab Clinical MaterialSaloumeh K Fischer, Melissa Cheu, Kun Peng, John B. Lowe, James Araujo
The AAPS Journal. 2017-01-01 - 298 citationsLebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studiesNicola A. Hanania, Michael Noonan, Jonathan Corren, Phillip E. Korenblat, Yanan Zheng
Thorax. 2015-05-22
Press Mentions
Alladapt Immunotherapeutics Announces Topline Pediatric Data from Phase 1/2 Harmony Study Evaluating ADP101 for the Treatment of Patients with Mono- and Multi-Food Allergy, as Presented at the European Academy of Allergy and Clinical Immunology Hybrid CongressJune 14th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
